Xu, Yaoxian
Kuppe, Christoph https://orcid.org/0000-0003-4597-9833
Perales-Patón, Javier https://orcid.org/0000-0003-0780-6683
Hayat, Sikander https://orcid.org/0000-0001-5919-8371
Kranz, Jennifer
Abdallah, Ali T.
Nagai, James
Li, Zhijian
Peisker, Fabian https://orcid.org/0000-0003-0123-8179
Saritas, Turgay https://orcid.org/0000-0002-6691-9218
Halder, Maurice https://orcid.org/0000-0003-2386-9684
Menzel, Sylvia
Hoeft, Konrad https://orcid.org/0000-0002-0265-0061
Kenter, Annegien https://orcid.org/0000-0002-1040-2308
Kim, Hyojin
van Roeyen, Claudia R. C.
Lehrke, Michael
Moellmann, Julia
Speer, Thimoteus https://orcid.org/0000-0002-2491-6393
Buhl, Eva M. https://orcid.org/0000-0003-0627-9228
Hoogenboezem, Remco
Boor, Peter https://orcid.org/0000-0001-9921-4284
Jansen, Jitske
Knopp, Cordula
Kurth, Ingo https://orcid.org/0000-0002-5642-8378
Smeets, Bart
Bindels, Eric https://orcid.org/0000-0001-9502-669X
Reinders, Marlies E. J.
Baan, Carla
Gribnau, Joost https://orcid.org/0000-0001-5645-4691
Hoorn, Ewout J.
Steffens, Joachim
Huber, Tobias B. https://orcid.org/0000-0001-7175-5062
Costa, Ivan https://orcid.org/0000-0003-2890-8697
Floege, Jürgen
Schneider, Rebekka K. https://orcid.org/0000-0002-0749-1565
Saez-Rodriguez, Julio https://orcid.org/0000-0002-8552-8976
Freedman, Benjamin S.
Kramann, Rafael https://orcid.org/0000-0003-4048-6351
Article History
Received: 11 November 2021
Accepted: 9 September 2022
First Online: 27 October 2022
Competing interests
: R.K. reports unrelated funding from Travere Therapeutics, Galapagos and Novo Nordisk and unrelated honoraria from Bayer, Pfizer, Grünenthal and Novo Nordisk. S.H. reports unrelated funding from Novo Nordisk. J.S.R. reports unrelated funding from GSK and Sanofi and unrelated fees from Travere Therapeutics and Astex Therapeutics. All other authors have nothing to disclose.